iC³: Innovation = Capital x Collaboration x Commercialization
|
10 Years & Beyond
Join the Renaissance — Register Now
September 16 - 17, 2025
|
The iC³ Life Science Summit brings together leaders and innovators to tackle challenges, explore new opportunities, and drive transformation in life sciences and healthcare.
This year, we are celebrating “10 Years and Beyond” with a focus on the powerful convergence of biology, technology, and AI — accelerating breakthroughs in precision medicine, biomanufacturing, and the future of healthcare.
|
If you have any questions about the Summit, please reach out to Jacqueline Ho at jho@biontx.org.
|
iC³ PRESENTATION OPPORTUNITIES
|
Act Now! Time is Running Out to
Submit Your Tech Transfer Application
Portal closes on Monday, July 28, 2025
|
2024 Tech Transfer winners and judges
|
Present your groundbreaking innovations at the 4th Annual Tech Transfer Showcase during BioNTX's iC³ Life Science Summit, an exclusive platform designed to connect academic institutions from Texas, Arkansas, Louisiana, New Mexico, Oklahoma, and Tennessee with top industry leaders and investors.
This event offers a unique opportunity to highlight your most promising intellectual property, explore potential collaborations, and secure funding, all while advancing the future of life sciences and technology.
|
Featuring John Crowley, BIO CEO as a Special Guest
|
AI in the Golden Age of Biotech: Shaping the Future of Innovation
|
We are in the golden age of biotechnology, where Artificial Intelligence is unlocking unprecedented opportunities in drug discovery, diagnostics, and personalized medicine. This session will explore how AI is accelerating research, improving patient outcomes, and reshaping the biotech landscape. Discover how AI technologies are driving the next wave of innovation and transforming the future of healthcare.
|
Beyond the Bench and the Boardroom:
Unlocking Federal & Alternative Funding in the New Policy Era
|
As federal priorities shift, access to non-dilutive funding and preclinical support is more critical—and complex—than ever. This session brings together experts from D.C., academia, and state agencies to demystify the evolving landscape. Learn how to navigate federal grants, tap into emerging resources, and align your work for long-term, mission-driven growth.
|
Talent, Tech & Trajectory — Building the
Life Science Workforce of Tomorrow
|
North Texas is building the future of biotech with bright minds and bold ideas. With AI, advanced therapeutics, and personalized medicine transforming life sciences, our region is stepping up with energy and vision.
This session highlights how academic institutions, industry leaders, and workforce partners are working together to create new pathways for talent—preparing the next generation to thrive and lead in a growing innovation economy right here in Texas.
|
EY Shares Key Insights on the Future of Biotech in Texas
|
BioNTX is pleased to present a session led by Ernst & Young, offering a timely analysis of how today’s shifting dealmaking and funding environment is shaping the Texas biotechnology landscape.
The Ernst & Young report not only provides a data-driven snapshot of where the industry stands today, it also outlines key trends, risks, and forward-looking strategies that can help companies across the life sciences ecosystem build resilience and pursue growth in an increasingly uncertain environment.
|
Biomanufacturing 101: Foundations
for a New Era of Cell & Gene Therapy
|
As advanced therapies move toward broader clinical adoption, biomanufacturing has become a critical component of the healthcare innovation pipeline. This session will provide a foundational overview of the systems and standards that support the production of biologics—including regulatory considerations, facility design, quality assurance, and workforce development.
Designed for stakeholders across the life sciences sector, this session will offer valuable insights into the infrastructure and operational excellence required to deliver safe, effective, and scalable therapies to patients.
|
North Texas Life Sciences Global Supply Chain Leadership
|
In today’s evolving life sciences and healthcare landscape, the strength of the supply chain plays a vital role in advancing innovation. North Texas is emerging as a leader by implementing strategies that emphasize resilience, efficiency, and transparency.
With robust infrastructure, a strong innovation ecosystem, and a culture of collaboration, North Texas is shaping new approaches to how critical resources move. From precise logistics to sustainable distribution models, the region is helping define how essential technologies, treatments, and knowledge reach global markets.
|
Stay Tuned: More Sessions Coming Soon
|
Mobilizing Innovation for the Nation’s Most Critical Needs
|
Advanced Technology International (ATI) is a mission-driven nonprofit that accelerates groundbreaking research to strengthen national security and serve the public good. By managing complex collaborations on behalf of the Department of Defense (DoD), ATI helps government sponsors define critical needs and rapidly source solutions from a curated network of leading innovators across industry and academia. With deep expertise in both Other Transaction Agreements (OTAs) and Federal Acquisition Regulation (FAR)-based programs, ATI delivers flexible, high-impact partnerships that drive technological advancement where it matters most.
ATI joins the 2025 iC³ Summit on September 17th at 10:35 AM with a session on Advancing National Health Initiatives Through Innovation. They will highlight how their portfolio of health-focused consortia is driving public-private partnerships to advance diagnostics, biomanufacturing, supply chain security, and rapid response to public health challenges.
|
Navigating Complex Legal Challenges in Life Sciences & Beyond
|
Polsinelli is a national law firm with over 1,200 attorneys providing expert legal and business guidance across industries like health care, technology, and life sciences. Their multidisciplinary team—attorneys, patent agents, and scientists—specializes in navigating the complex challenges of innovation, regulation, and intellectual property. From startups to established companies, Polsinelli offers tailored legal support in areas including corporate governance, licensing, M&A, FDA compliance, patent strategy, and more.
|
Driving Medical Breakthroughs That
Transform Lives and Communities
|
UT Southwestern is one of the nation’s leading academic medical centers, combining cutting-edge biomedical research with world-class clinical care and education. Home to six Nobel Laureates and dozens of members of the National Academies, its faculty of over 3,200 drives medical innovation and rapidly translates discoveries into patient care. UT Southwestern physicians deliver care across 80+ specialties, serving millions of patients annually through inpatient, emergency, and outpatient services.
|
Strategic Advisory and Technology Solutions
for the Life Science Industries
|
Sikich is a global professional services firm specializing in technology-enabled solutions that help organizations improve performance and achieve strategic goals. As one of the largest CPA firms in the U.S., Sikich delivers a broad range of services—from audit and tax to digital transformation and business advisory—tailored to meet the needs of corporations, nonprofits, government agencies, and highly regulated industries like life sciences.
|
Special Thank You To Our iC³ Sponsors
|
iC³: Innovation = Capital x Collaboration x Commercialization
|
Dates
Tuesday, September 16: 7:00am - 7:00pm
Wednesday, September 17: 8:00am - 3:30pm
|
Location
Hilton Anatole
2201 N Stemmons Freeway, Dallas, TX 75207
|
If you have any questions about the Summit, please reach out to Jacqueline Ho at jho@biontx.org.
|
Time Is Running Out, Book Your Hotel Room Now!
|
Only one month left to secure your exclusive discounted rate at the Hilton Anatole, available only to attendees of the 2025 iC³ Summit.
Reserve your room now using the special booking link or by contacting the reservations team directly before availability runs out.
Do not miss this chance to stay close to the action and connect with the trailblazers driving the future of life sciences innovation.
|
|
